Literature DB >> 19053579

Diastereoselective, three-component cascade synthesis of tetrahydrofurans and tetrahydropyrans employing the tandem Mukaiyama aldol-lactonization process.

T Andrew Mitchell1, Cunxiang Zhao, Daniel Romo.   

Abstract

A full account of studies leading to the development of a cascade sequence that generates as many as two C-C bonds, one C-O bond, and three new stereocenters providing substituted tetrahydrofurans (THFs) from simple gamma-ketoaldehydes and thiopyridyl ketene acetals is described. The process involves a tandem Mukaiyama aldol-lactonization (TMAL) and accumulated evidence suggests the intermediacy of a silylated beta-lactone that is intercepted by the pendant ketone. Formation of a cyclic oxocarbenium is followed by reduction with silicon-based nucleophiles leading to a highly diastereoselective synthesis of tetrahydrofurans. This cascade process has now been extended to the synthesis of tetrahydropyrans from simple delta-ketoaldehydes. The stereochemical outcome of the cascade processes described was determined by NOE correlations, coupling constant analysis, and X-ray crystallography of the derived oxygen heterocycles and is in accord with established and recently proposed models for nucleophilic additions to cyclic 5- and 6-membered oxocarbenium ions. The utility of this process was demonstrated by the synthesis of the tetrahydrofuran fragment of colopsinol B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053579      PMCID: PMC2754051          DOI: 10.1021/jo801604k

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  57 in total

1.  Tandem reactions, cascade sequences, and biomimetic strategies in total synthesis.

Authors:  K C Nicolaou; Tamsyn Montagnon; Scott A Snyder
Journal:  Chem Commun (Camb)       Date:  2003-03-07       Impact factor: 6.222

2.  Catalytic asymmetric assembly of stereodefined propionate units: an enantioselective total synthesis of (-)-pironetin.

Authors:  Xiaoqiang Shen; Andrew S Wasmuth; Junping Zhao; Cheng Zhu; Scott G Nelson
Journal:  J Am Chem Soc       Date:  2006-06-14       Impact factor: 15.419

3.  5-Exocyclic products, 2,3,5-trisubstituted tetrahydrofurans via Prins-type cyclization.

Authors:  Satish N Chavre; Hyunah Choo; Joo Hwan Cha; Ae Nim Pae; Kyung Il Choi; Yong Seo Cho
Journal:  Org Lett       Date:  2006-08-03       Impact factor: 6.005

4.  A Sakurai-Prins-Ritter sequence for the three-component diastereoselective synthesis of 4-amino tetrahydropyrans.

Authors:  Oleg L Epstein; Tomislav Rovis
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

5.  A Ru-catalyzed tandem alkyne-enone coupling/Michael addition: synthesis of 4-methylene-2,6-cis-tetrahydropyrans.

Authors:  Barry M Trost; Hanbiao Yang; Georg Wuitschik
Journal:  Org Lett       Date:  2005-10-13       Impact factor: 6.005

6.  Tetrahydropyran rings from a Mukaiyama-Michael cascade reaction.

Authors:  Megan L Bolla; Brian Patterson; Scott D Rychnovsky
Journal:  J Am Chem Soc       Date:  2005-11-23       Impact factor: 15.419

7.  Asymmetric construction of quaternary centers by enantioselective allylation: application to the synthesis of the serotonin antagonist LY426965.

Authors:  Scott E Denmark; Jiping Fu
Journal:  Org Lett       Date:  2002-05-30       Impact factor: 6.005

8.  Concise total synthesis of (+)-brefeldin A: a combined beta-lactone/cross-metathesis-based strategy.

Authors:  Yingcai Wang; Daniel Romo
Journal:  Org Lett       Date:  2002-09-19       Impact factor: 6.005

9.  Highly stereoselective prins cyclization of (Z)- and (E)-gamma-brominated homoallylic alcohols to 2,4,5,6-tetrasubstituted tetrahydropyrans.

Authors:  Feng Liu; Teck-Peng Loh
Journal:  Org Lett       Date:  2007-04-26       Impact factor: 6.005

10.  A diastereoselective ring contraction of 1,3-dioxepins to 2,3,4-trisubstituted and tetrasubstituted tetrahydrofurans.

Authors:  Christopher G Nasveschuk; Tomislav Rovis
Journal:  J Org Chem       Date:  2007-12-19       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.